Sökning: "anna rosen"
Visar resultat 1 - 5 av 8 avhandlingar innehållade orden anna rosen.
1. Mass screening for celiac disease in 12-year-olds : Finding them and then what?
Sammanfattning : Background Mass screening for celiac disease (CD) as a public health intervention is controversial. Before implementation, a suitable screening strategy should be outlined, and the acceptability of the screening scrutinized. Also, the benefits of early detection and possible negative consequences should be explored and compared. LÄS MER
2. Performance determinants and classification in paracanoe
Sammanfattning : Valid classification systems are vital for Paralympic sports in order to minimise the impact of impairment on sports performance. To achieve valid classification, each Paralympic sport must develop evidence-based classification systems by examining the impact of impairment on key performance determinants. LÄS MER
3. Open Source Business Model : Balancing Customers and Community
Sammanfattning : Free and Open Source Software has not only increased researchers’ interest about community-driven software development, but lately, interest from commercial actors increased as well. In addition, some scientists have claimed that Open Source Software has entered a new phase: OSS 2.0. LÄS MER
4. Immunological Studies in Malignant Melanoma : Importance of TNF and the Thioredoxin System
Sammanfattning : Malignant melanoma is a tumor whose incidence is dramatically increasing in persons with light-coloured skin in all parts of the world. Due to its resistance against traditional chemo- and radiotherapy, melanoma has been a favourite target of alternative therapies, in particular those involving immunological mechanisms. LÄS MER
5. Restricted antigen recognition in B cell chronic lymphocytic leukemia
Sammanfattning : Chronic lymphocytic leukemia (CLL) cells are considered to be derived from antigen-exposed B cells. To further explore the antigen-driven selection behind the leukemogenesis of CLL, we performed immunoglobulin (Ig) specificity screening of 7 CLL cell lines and 23 primary CLL clones from patient peripheral blood. LÄS MER